CN1312158C - Method for preparing cefixime - Google Patents

Method for preparing cefixime Download PDF

Info

Publication number
CN1312158C
CN1312158C CNB2005100135372A CN200510013537A CN1312158C CN 1312158 C CN1312158 C CN 1312158C CN B2005100135372 A CNB2005100135372 A CN B2005100135372A CN 200510013537 A CN200510013537 A CN 200510013537A CN 1312158 C CN1312158 C CN 1312158C
Authority
CN
China
Prior art keywords
acid
compound
cefixime
preparation
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB2005100135372A
Other languages
Chinese (zh)
Other versions
CN1696134A (en
Inventor
周永健
孟红
赵平
边颖
蔡毅
李玉荃
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Pharmaceutical Tech Development Co ltd
Original Assignee
Tianjin Pharmaceutical Tech Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Pharmaceutical Tech Development Co ltd filed Critical Tianjin Pharmaceutical Tech Development Co ltd
Priority to CNB2005100135372A priority Critical patent/CN1312158C/en
Publication of CN1696134A publication Critical patent/CN1696134A/en
Application granted granted Critical
Publication of CN1312158C publication Critical patent/CN1312158C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

The present invention discloses a method for preparing cefixime from perhalate. The method comprises the following steps: a compound with a structural formula (III) reacts with perhalognic acid and organic protonic acid in organic solvent to prepare cefixime perhalate (I) by a protective-radical removing reaction, and then the compound with a structural formula (I) is refreed to obtain cefixime (II). The cefixime prepared by the present invention has the advantages of high purity, shallow appearance color and high yield. The present invention avoids inconvenience caused by using large amounts of alkali to extract the cefixime, is a cefixime preparing method having the advantages of low price and high efficiency, and is especially suitable for large-scale industrial production.

Description

A kind of preparation method of Cefixime Micronized
Technical field
The invention belongs to technical field of medicine synthesis, relate to the synthetic of cynnematin, in particular, is the preparation method of third generation oral cephalosporin Cefixime Micronized.
Background technology
Cefixime Micronized (II), chemical name: (6R, 7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(carboxymethoxyl imino-) kharophen]-8-oxo-3-vinyl-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid trihydrate is semi-synthetic third generation oral cephalosporin, gram-positive microorganism and Gram-negative bacteria all there are stronger anti-microbial effect, highly stable to β-Nei Xiananmei.
According to bibliographical information, Cefixime Micronized generally makes by following synthetic method.
R wherein 1For hydrogen or carboxyl-protecting group to methoxybenzyl, diphenyl-methyl etc., R 2Be lower aliphatic alkyl such as carboxy protective ylmethyl, tertiary butyl, Z is chlorine or mercaptobenzothiazole etc.
Compound (III) is transformed into Cefixime Micronized (II) by deprotection base under alkalescence or acidic conditions.Because cynnematin is to the alkali instability, deprotection base under alkaline condition, yield low, of poor quality (DE19846449).In addition; carry out deprotection reaction at acidic conditions; as: with method [the Tetrahedron Lett. of aluminum chloride/methyl-phenoxide; 2793 (1979)], with the method (EP030630) of trifluoroacetic acid/methyl-phenoxide, with 99% formic acid be the method (WO98/31685) of deprotection agent and solvent, with the method [J.Org.Chem. of phenols; 56; 3633 (1991)] or the like; the method of these acidic conditions deprotection bases; because a large amount of protonic acids or the existence of strong lewis acid; side reactions such as cis-trans isomerization easily take place, and operation is loaded down with trivial details, yield is low, cost is high.Have among the WO98/31685 open again; during deprotection reaction (99% formic acid); add a large amount of vitriol oil formation Cefixime Micronized vitriol and separate out, because by product also becomes to salt out gained vitriol purity difference, low, the sad filter of yield, the easy moisture absorption, difficult dry with sulfuric acid.
Summary of the invention
The objective of the invention is to, overcome above-mentioned shortcoming of the prior art, a kind of preparation method of Cefixime Micronized is provided with not enough.
The present invention is achieved by following technical proposals: it comprises by structural formula (III) compound in organic solvent, with high hydracid and organic proton acid-respons, makes the deprotection reaction of Cefixime Micronized perhalide (I); The free again Cefixime Micronized (II) that obtains of structural formula (I) compound.
Figure C20051001353700052
Wherein: R 1The expression hydrogen, to methoxybenzyl, diphenyl-methyl etc., R 2Lower aliphatic alkyl such as expression methyl, tertiary butyl.
Deprotection reaction by structural formula (III) compound generating structure formula (I) of the present invention carries out under 0-100 ℃ of temperature condition, preferred 5-50 ℃.
Structural formula of the present invention (I) compound is free again can adopt mineral alkali for example sodium hydroxide, ammoniacal liquor, saturated solution of sodium carbonate, saturated solution of sodium bicarbonate or the like dissociate, make Cefixime Micronized (II).
High hydracid of the present invention is perchloric acid, hyperbromic acid, Periodic acid; Its consumption is a 0.5-5 times of equivalent with respect to compound (III).Preferred 1-2 times of equivalent.
The organic protonic acid that uses among the present invention, the weak acid of preferred pKa=3-5, as: formic acid, acetate, Mono Chloro Acetic Acid, trifluoroacetic acid etc. replace or unsubstituted low-grade alkyl carboxylic acid, replacement such as phenylformic acid, toluylic acid or unsubstituted aromatic carboxylic acid etc.The consumption of organic protonic acid is a 1-20 times of equivalent with respect to compound (III), preferred 3-10 times of equivalent.
Organic solvent of the present invention is ester class, nitrile, aromatic hydrocarbons, ketone, halogenated hydrocarbon.Nitriles such as acetonitrile, propionitrile, butyronitrile for example, aromatic hydrocarbons such as benzene, toluene, ester classes such as methyl-formiate, ethyl formate, butyl formate, methyl acetate, ethyl acetate, butylacetate, ketone such as acetone, methyl butyl ketone, halogenated hydrocarbons such as methylene dichloride, chloroform, ethylene dichloride, tetracol phenixin, preferred solvent is benzene, toluene, tetracol phenixin, chloroform, methylene dichloride, ethylene dichloride.The consumption of organic solvent, 1g is generally 2-100ml with respect to compound (III), preferred 5-50ml.
The preparation method's of Cefixime Micronized of the present invention concrete synthetic route is as follows:
Figure C20051001353700071
Wherein: R 1The expression hydrogen, to methoxybenzyl, diphenyl-methyl etc., R 2Lower aliphatic alkyl such as expression methyl, tertiary butyl.
The preparation method of Cefixime Micronized of the present invention compares with prior preparation method has following significant positively effect:
The compound (III) of band protecting group is sloughed protecting group with high hydracid and organic protonic acid in organic solvent, form highly purified Cefixime Micronized perhalide (I) and separate out, and Cefixime Micronized perhalide (I) is again with the free Cefixime Micronized (II) that obtains of a spot of alkali.Cefixime Micronized purity height, appearance color that this method obtains are shallow, yield height, and the inconvenience of having avoided a large amount of alkaline extraction Cefixime Micronizeds of direct usefulness to bring.Be a cheapness, prepare the method for Cefixime Micronized efficiently, be particularly suitable for large-scale industrial production.
Embodiment
The present invention is further illustrated below in conjunction with embodiment, but the scope of protection of present invention is not limited in the following specific embodiment operation that provides.
Embodiment 1.
In the reaction flask of 500ml, add 7-[[(2-amino-4-thiazole)-[(tertiary butyl oxygen acetyl) oxime] acetyl] amino]-3-vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid [III] 15g, methylene dichloride 150ml, formic acid 21ml, perchloric acid 12ml was warming up to 30 ℃ of insulated and stirred 2 hours.Be cooled to below 5 ℃, separate out solid, filter, the dry light yellow 7-[[(2-amino-4-thiazole that gets)-[(carboxymethyl) oxime] acetyl] amino]-3-vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid perchlorate [I] 16.5g, yield 91.7%, HPLC 98%. 1H-NMR(DMSO):3.6,3.8(ABq,2H),4.69(s,2H),5.20(d,1H),5.31(d,1H),5.59(d,1H),5.79(dd,1H),6.92(dd,1H),6.99(s,1H),9.71(d,1H)。
Embodiment 2
In the reaction flask of 500ml, add 7-[[(2-amino-4-thiazole)-[(tertiary butyl oxygen acetyl) oxime] acetyl] amino]-3-7 vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid [III] 5g, ethyl acetate 100ml, formic acid 3ml, perchloric acid 2ml was warming up to 40 ℃ of insulated and stirred 1 hour.Be cooled to below 5 ℃, separate out solid, filter, the dry light yellow 7-[[(2-amino-4-thiazole that gets)-[(carboxymethyl) oxime] acetyl] amino]-3-vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid perchlorate [I] 5.2g, yield 87%, HPLC 98.2%. 1H-NMR(DMSO):3.6,3.8(ABq,2H),4.69(s,2H),5.20(d,1H),5.31(d,1H),5.59(d,1H),5.79(dd,1H),6.92(dd,1H),6.99(s,1H),9.71(d,1H)。
Embodiment 3
In the reaction flask of 500ml, with 7-[[(2-amino-4-thiazole)-[(carboxymethyl) oxime] acetyl] amino]-3-vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid perchlorate [I] 16g is suspended in the water of 150ml, be cooled to below 5 ℃, drip saturated solution of sodium carbonate, after the solid stirring and dissolving, add carbon decolouring 1 hour.Filter, filtrate transfers to pH2.5 with the hydrochloric acid of 4N, and 5 ℃ were stirred 0.5 hour, and leached solid, the dry 7-[[(2-amino-4-thiazole that gets)-and [(carboxymethyl) oxime] acetyl] amino]-3-vinyl-8-oxygen-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxylic acid (II, Cefixime Micronized) 12g.HPLC?98.3%
1H-NMR(DMSO-D6):3.54,3.8(ABq,2H),4.58(s,2H),5.20(d,1H),5.31(d,1H),5.59(d,1H),5.80(dd,1H),6.80(s,2H),6.86(dd,2H),7.24(s,2H),9.54(d,1H)。
IR:3536cm -1,3297cm -1,2948cm -1,3300-2500cm -1,1771cm -1,1668cm -1,1096cm -1

Claims (6)

1, a kind of preparation method of Cefixime Micronized is characterized in that, comprises by structural formula (III) compound in organic solvent, with high hydracid and organic proton acid-respons, makes the deprotection reaction of Cefixime Micronized perhalide (I); The free again Cefixime Micronized (II) that obtains of structural formula (I) compound;
Figure C2005100135370002C1
Wherein: R 1The expression hydrogen, to methoxybenzyl, diphenyl-methyl, R 2Expression methyl, tertiary butyl lower aliphatic alkyl.
2, preparation method as claimed in claim 1 is characterized in that, described deprotection reaction by structural formula (III) compound generating structure formula (I) carries out under 0-100 ℃ of temperature condition.
3, preparation method as claimed in claim 1 is characterized in that, the free more free Cefixime Micronized (II) that makes of mineral alkali that adopts of described structural formula (I) compound.
4, preparation method as claimed in claim 1 is characterized in that, described high hydracid is perchloric acid, hyperbromic acid, Periodic acid; Its consumption is a 0.5-5 times of equivalent with respect to compound (III).
5, preparation method as claimed in claim 1 is characterized in that, described organic protonic acid is formic acid, acetate, Mono Chloro Acetic Acid, trifluoroacetic acid or phenylformic acid, toluylic acid; Its consumption is a 1-20 times of equivalent with respect to compound (III).
6, preparation method as claimed in claim 1 is characterized in that, described organic solvent is ester class, nitrile, aromatic hydrocarbons, ketone, halogenated hydrocarbon.
CNB2005100135372A 2005-05-20 2005-05-20 Method for preparing cefixime Active CN1312158C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100135372A CN1312158C (en) 2005-05-20 2005-05-20 Method for preparing cefixime

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100135372A CN1312158C (en) 2005-05-20 2005-05-20 Method for preparing cefixime

Publications (2)

Publication Number Publication Date
CN1696134A CN1696134A (en) 2005-11-16
CN1312158C true CN1312158C (en) 2007-04-25

Family

ID=35349043

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100135372A Active CN1312158C (en) 2005-05-20 2005-05-20 Method for preparing cefixime

Country Status (1)

Country Link
CN (1) CN1312158C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731529A (en) * 2012-06-28 2012-10-17 广州白云山制药股份有限公司广州白云山化学制药厂 Refining method for cefixime
CN104004003B (en) * 2013-02-22 2016-05-25 广州白云山医药集团股份有限公司白云山制药总厂 Cefixime derivative and its production and use
CN103980293B (en) * 2014-05-21 2016-08-17 广州白云山医药集团股份有限公司白云山化学制药厂 3-vinyl-7-(thiazole methoxyimino) preparation method of Cephalosporanic acid

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258041A (en) * 1978-05-26 1981-03-24 Glaxo Group Limited (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof
WO1995033753A1 (en) * 1994-06-03 1995-12-14 Marcham Trading & Investment Ltd. Process for the preparation of trihydrated cefixime
CN1295576A (en) * 1998-04-02 2001-05-16 生物化学有限公司 Process for purification of cephalosporin derivative
US6277996B1 (en) * 2000-03-06 2001-08-21 Hanmi Fine Chemicals Co., Ltd. Thiazole compound and a process thereof
US6313289B1 (en) * 1997-01-16 2001-11-06 Biochemie Gesellschaft M.B.H. Purification process
US6384212B1 (en) * 2000-03-20 2002-05-07 Hanmi Fine Chemicals Co., Ltd. Process for preparing cephalosporin antibiotics using new thiazole compound
US20040082560A1 (en) * 2002-10-24 2004-04-29 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cefixime
US20050032771A1 (en) * 2001-11-09 2005-02-10 Walter Cabri Process for the preparation of cefixime via alkyl-or aryl-sulfonates

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258041A (en) * 1978-05-26 1981-03-24 Glaxo Group Limited (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof
WO1995033753A1 (en) * 1994-06-03 1995-12-14 Marcham Trading & Investment Ltd. Process for the preparation of trihydrated cefixime
US6313289B1 (en) * 1997-01-16 2001-11-06 Biochemie Gesellschaft M.B.H. Purification process
CN1295576A (en) * 1998-04-02 2001-05-16 生物化学有限公司 Process for purification of cephalosporin derivative
US6277996B1 (en) * 2000-03-06 2001-08-21 Hanmi Fine Chemicals Co., Ltd. Thiazole compound and a process thereof
US6384212B1 (en) * 2000-03-20 2002-05-07 Hanmi Fine Chemicals Co., Ltd. Process for preparing cephalosporin antibiotics using new thiazole compound
US20050032771A1 (en) * 2001-11-09 2005-02-10 Walter Cabri Process for the preparation of cefixime via alkyl-or aryl-sulfonates
US20040082560A1 (en) * 2002-10-24 2004-04-29 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cefixime
US6800755B2 (en) * 2002-10-24 2004-10-05 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cefixime

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
头孢克肟的合成 胡艾希等,中国医药工业杂志,第35卷第1期 2004 *

Also Published As

Publication number Publication date
CN1696134A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
CN101235045A (en) Method for preparing cefoxitin sodium
CN101613361A (en) Preparing cefoxitin sodium
JP6694109B2 (en) Method for preparing improved 5R-benzyloxyaminopiperidine-2S-formate ester and its oxalate salt
EP3153496B1 (en) Method for preparing azetidinone compound and intermediate of azetidinone compound
US20210332060A1 (en) A Simple Process for Preparing Avibactam
CN102219794A (en) Preparation method of ceftizoxime sodium
CN1312158C (en) Method for preparing cefixime
CN104402909A (en) Synthetic method of cefoxitin acid
JP3751880B2 (en) Method for producing high-purity cefpodoxime proxetil
EP2276740B1 (en) Improved process for preparing quinoline-3-carboxamide derivatives
CN102304140A (en) Preparation method of cefodizime sodium
US20190263812A1 (en) Process for preparing an intermediate for avibactam
US20190263813A1 (en) A simple Process for Preparing an Intermediate for Avibactam
US20170233351A1 (en) Process for the Preparation of Olaparib and Intermediates Thereof
CN105859747A (en) Cefepime dihydrochloride preparation method suitable for industrial production
CN104327098B (en) A kind of cefetamet diisopropylamine
WO2015131299A1 (en) Method of preparation and chiral inversion of chiral-1-t-butoxycarbonyl-3-hydroxy piperidine
JP2003511455A (en) Method for producing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid
US20030088094A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CN101486720A (en) Cefodizime sodium compound and method for synthesizing the same
US8129536B2 (en) Method for the purification of lansoprazole
CN106810485A (en) A kind of Preparation Method And Their Intermediate of chiral boxidine alkanone
CN1644583A (en) Cephe alkene onium salt compound and its preparation and use in preparation of cefepime
CN111253405B (en) Preparation method of biapenem intermediate
CN108299469A (en) A kind of preparation method of cefotiam chloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Tianjin Pharmaceutical Group Gencom Pharmaceutical Co., Ltd.

Assignor: Tianjin Pharmaceutical Group Technology Development Co., Ltd.

Contract fulfillment period: 2009.3.5 to 2014.3.5 contract change

Contract record no.: 2009120000099

Denomination of invention: Method for preparing cefixime

Granted publication date: 20070425

License type: Exclusive license

Record date: 2009.7.9

LIC Patent licence contract for exploitation submitted for record

Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.3.5 TO 2014.3.5; CHANGE OF CONTRACT

Name of requester: TIANJIN MEDICINE GROUP JINKANG PHARMACEUTICAL CO.,

Effective date: 20090709